Stocks That Hit 52-Week Lows On Wednesday
Wednesday's session saw 784 companies set new 52-week lows.
Stocks That Hit 52-Week Lows On Tuesday
During Tuesday, 581 stocks hit new 52-week lows.
Interesting Highlights From Today's 52-Week Lows
Meta Platforms (NASDAQ:FB) was the biggest company on a market cap basis to set a new 52-week low.
Stocks That Hit 52-Week Lows On Friday
During Friday's morning session, 234 stocks hit new 52-week lows.
63 Biggest Movers From Yesterday
Gainers
InMed Pharmaceuticals Inc. (NASDAQ: INM) shares gained 39.1% to close at $1.05 on Thursday. The company recently said its CFO Bruce Colwill will retire.
10 Biggest Price Target Changes For Wednesday
SVB Leerink cut the price target on TCR2 Therapeutics Inc. (NASDAQ: TCRR) from $7 to $3. TCR2 Therapeutics shares rose 16% to close at $3.19 on Tuesday.
Piper Sandler Downgrades Aligos Therapeutics to Neutral, Lowers Price Target to $4
Piper Sandler analyst Yasmeen Rahimi downgrades Aligos Therapeutics (NASDAQ:ALGS) from Overweight to Neutral and lowers the price target from $15 to $4.
Aligos Pulls Plug On Early-Stage Chronic Hepatitis B Treatment Candidate
Aligos Therapeutics Inc (NASDAQ: ALGS) has
Aligos Discontinues Development Of Its Antisense Oligonucleotide Drug Candidate ALG-020572 In Subjects With Chronic Hepatitis B, Says Is Pivoting Internal Strategic Emphasis To Its Small Molecule Portfolio
Dosing in the first cohort discontinued after multiple reports of ALT flares suggestive of drug-induced liver toxicity
Funds will be redirected to support ongoing clinical programs, including ALG-000184 (Class-II
Looking Into Aligos Therapeutics’s Return On Capital Employed
Aligos Therapeutics (NASDAQ:ALGS) brought in sales totaling $367.00 thousand during Q4 according to data provided by Benzinga Pro. However, earnings decreased 13.86%, resulting in a loss of $37.71 million.